LONDON (AP) — Britain became the first country to authorize AstraZeneca’s inexpensive, easy-to-handle COVID-19 vaccine Wednesday, gaining another weapon against the virus amid a resurgence so severe that the government extended lockdowns to three-quarters of England’s population. The country also changed course by deciding to dispense the first dose of its vaccines to as many people as possible right away, to give them at least some protection. Until now, authorities have been holding… Source link
Read More »AstraZeneca could expand US trial to pursue 90% efficacious vaccine
AstraZeneca’s (AZN) positive interim results for its COVID-19 vaccine Monday was met with some confusion as health experts and Wall Street attempted to parse the company’s “up to 90%” and “average 70%” vaccine efficacy claims. The vaccine candidate was tested in two different ways, resulting in two different efficacy rates — 62% and 90%— which the company averaged at 70%. The lower efficacy was from two full doses given a month apart, the higher efficacy came from the first… Source link
Read More »